Real-time enrollment status for this aml (acute myeloid leukemia) clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:12 PM UTC
| NCT Number | NCT07486713 |
| Recruiting Status | Recruiting |
| Condition | AML (Acute Myeloid Leukemia) |
| Phase | PHASE4 |
| Target Enrollment | 16 participants |
| Active Locations | 2 sites in the US |
| Sponsor | Rigel Pharmaceuticals |
| Last Updated on CT.gov | August 11, 2026 (2 weeks ago) |
As of August 31, 2026: Clinical trial NCT07486713 is currently recruiting participants. This phase4 study for aml (acute myeloid leukemia) is actively seeking new participants at 2 locations across the United States. The study is sponsored by Rigel Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07486713 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07486713 was last updated 2 weeks ago (August 11, 2026). HelloStudys verifies this status automatically.